WW2-13751-20198
4 vaccinations
4 coded responses
49 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Registered in v-safe
-
2020-12-24
Dose 1 — Pfizer-BioNTech
- 2020-12-24
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-07
- 2021-01-14
-
2021-01-15
Dose 2 — Pfizer-BioNTech
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-22
- 2021-02-26
- 2021-04-19
- 2021-07-16
- 2022-01-15
-
2022-04-01
Dose 3 — Pfizer-BioNTech
- 2022-04-01
-
2022-04-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2022-04-03
- 2022-04-04
- 2022-04-05
- 2022-04-07
- 2022-04-08
- 2022-04-17
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
-
2022-07-03
Survey response — 3 months, dose 3MedDRA: Pregnancy, Vaginal haemorrhage — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Vaginal bleeding during pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-07-03
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-07-05
Call successfulParticipant prefers to complete VAERS report online
- 2022-09-30
-
2022-11-20
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-21
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-11-22
Survey response — days 1–6 daily, dose 4MedDRA: Hyperhidrosis — Feeling: Good · Site: PainFree text: SweatingMedDRA releases: 2024-11 · check-in free text available
-
2022-11-23
Survey response — days 1–6 daily, dose 4MedDRA: Nasal congestion — Feeling: Fair · Site: PainFree text: Nasal congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-24
Survey response — days 1–6 daily, dose 4MedDRA: Nasal congestion — Feeling: FairFree text: Nasal cobgestionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-27
- 2022-12-06
- 2022-12-11
- 2022-12-18
- 2023-01-06
- 2023-02-19
- 2023-05-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2022-04-01 | Pfizer-BioNTech | No |
| 4 | 2022-11-20 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | priority 2/3 | |
| 2022-07-03 | Successful 2022-07-05 |
Participant prefers to complete VAERS report online |
Free text
Release 12 — 3 months, dose 3
Symptoms: Vaginal bleeding during pregnancy
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Sweating
Systemic reaction (other): Nasal congestion
Systemic reaction (other): Nasal cobgestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SD | Vaginal haemorrhage | · | · | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release